Adcendo, a biotech company pioneering the development of first and best-in-class ADCs for cancers with a high unmet medical need, today announced that the U.S. Food & Drug Administration (FDA) has ...

The results were alarming. Among PPI users, 5.6% reported kidney-related problems, compared to just 0.7% of those taking ...

New study shows dementia patients who are on antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), ...

Nick Alves was 19 when a psychiatrist offered him the antidepressant Trintellix to treat his moderate anxiety and depression ...

Scientists at the (UNIGE) have developed a tool that uses light to precisely control where and when a drug becomes active, ensuring it works exactly where it's needed. For medical treatments to be ...

The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...

A newly published review in Genes & Diseases explores the oncogenic activation of PIK3CA in cancer and highlights emerging ...

A real-world analysis suggests antidepressants may lead to faster cognitive decline in patients with dementia, but experts ...

The following is a summary of “Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving ...

Swedish scientists examining 19,000 patients taking antidepressants experienced changes in their brain function compared to ...

VANCOUVER, BC / ACCESS Newswire / February 24, 2025 / Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding it ...